Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
What is your approach to biologic therapy in older adults (80+) and CKD with RA?
Related Questions
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
How would you approach rheumatoid arthritis treatment for widespread large rheumatoid nodules but no active synovitis or subjective joint pain?
Would you escalate therapy in a patient with rheumatoid arthritis without synovitis, but a new rheumatoid nodule?
How do you counsel patients with RA stable on csDMARDs on whether to attempt tapering or not?
How do you approach treating a patient with RA and cirrhosis who did not respond to csDMARDs?
How would you approach a patient with seronegative RA and ILD?
If subdeltoid bursitis, bicipital tenosynovitis, and femoroacetabular synovitis are commonly present in PMR, why are they not included in the criteria for PMR and how are they differentiated from elderly onset RA where presentation is often atypical and more proximal?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Would you add abatacept to treat active inflammatory arthritis in a patient with history of RA-ILD who is already taking mycophenolate?
How would you manage a patient with erosive seronegative rheumatoid arthritis with IgG and IgM deficiency?
